Technavio expects global gastroesophageal reflux disease (GERD) market to reach over $8 billion by 2020

Renewable energy

 

This industry research report includes a detailed segmentation of the global GERD market by drug class (proton pumps inhibitors, H2 receptor antagonists, antacids, prokinetics, and CAM), by route of administration (oral and parenteral), and by dosage form (solid and liquids). It also outlines the market shares for key regions such as the Americas, APAC, and Europe. The top vendors analyzed in this report are AstraZeneca, Eisai, GlaxoSmithKline, Johnson & Johnson, and Takeda.

Technavio’s market research analysts estimate the global GERD market, to grow at a CAGR of more than 2% between 2016 and 2020. The advent of cost-effective over-the-counter (OTC) drugs is one of the primary drivers of the GERD market. Many patients prefer OTC drugs as they are extremely cost effective. The Americas is the highest revenue-generating region in the global GERD market.

The new market research report from Technavio provides a breakdown and analysis of the GERD segments by technology.

“The oral route of drug administration is the most preferred route of drug administration for GERD symptoms. The drugs administered through this route have to undergo first-pass metabolism and can be administered as tablets, capsules, and oral liquids. This route’s high degree of safety will result in its augmented preference during the forecast period,” says Imran Mushtaq, Industry Manager, Healthcare & Lifesciences, Technavio Research.

Technavio market research analysts have estimated the antacid segment to account for more than 61% of the total market share during the forecast period. This segment consists of drugs that contain weak bases. These bases react with stomach acids to neutralize and release salt and water. The augmented use of antacid drugs like Alka-Seltzer, Maalox Advanced Regular Strength, Pepto-bismol, Rolaids, and Mylanta will result in the strong growth of this market segment during the estimated period.

The leading vendors in the global GERD market are AstraZeneca, Eisai, GlaxoSmithKline, Johnson & Johnson, and Takeda. This market is highly competitive owing to the presence of numerous small and large players that operate on a local or global scale. The vendors in this market compete on the basis of price, quality, and innovation to gain maximum market traction during the forecast period.

A more detailed analysis is available in the Technavio report, Global GERD Market 2016-2020.

We can customize reports by other regions and specific segments upon request.

Other related reports: